About ABIVAX Société Anonyme
French clinical-stage biotech developing therapies for ulcerative colitis and Crohn's disease. No dividend, high volatility around Phase 3 data readouts. ADR structure may mean wider options spreads — binary clinical risk makes CSP selling more of a wager than an income strategy.
Biotechnology